Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Don Tran

Optometrist Huntington Beach, CA Doctor of Optometry

NPI 1063870574 CMS profile 1585110

15061 Springdale St, Ste 103, Huntington Beach, CA 92649

Open in the dashboard

General payments

$10,775

478 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Don Tran of Huntington Beach, CA is reported in the CMS Open Payments database as having received $10,775 across 478 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,043 83
2024 General $1,718 76
2023 General $1,226 63
2022 General $1,570 71
2021 General $2,159 92
2020 General $1,033 44
2019 General $1,026 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Don Tran
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Don Tran were reported at $2,043. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Don Tran Optometrist median Middle half National median
2019 $1,026 $159 $67–$371 $163
2020 $1,033 $72 $29–$165 $114
2021 $2,159 $125 $46–$292 $132
2022 $1,570 $162 $66–$374 $149
2023 $1,226 $177 $72–$406 $160
2024 $1,718 $188 $77–$427 $164
2025 $2,043 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mallinckrodt Hospital Products Inc. $1,974 117 payments
  2. Alcon Vision LLC $1,307 52 payments
  3. Aerie Pharmaceuticals, Inc. $1,090 55 payments
  4. Dompe US, Inc. $1,066 36 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $870 38 payments
  6. AbbVie, Inc. $811 27 payments
  7. Bausch & Lomb Americas Inc. $776 41 payments
  8. Sun Pharmaceutical Industries Inc. $590 33 payments
  9. Allergan Inc. $508 15 payments
  10. Tarsus Pharmaceuticals, Inc. $403 11 payments
  11. Other $1,378 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,762 477 payments
  2. Entertainment $13 1 payment
Products named General payments · program years 2019–2025
  1. ACTHAR $1,974 117 payments
  2. OXERVATE $1,066 36 payments
  3. rhopressa $997 44 payments
  4. rocklatan Glaucoma $997 44 payments
  5. VYZULTA $781 38 payments
  6. Rocklatan Ophthalmology $722 29 payments
  7. Cequa $445 22 payments
  8. XDEMVY $403 11 payments
  9. VUITY $380 11 payments
  10. LUMIGAN $368 14 payments
  11. Other $5,178 230 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

478 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record